Table 2 Effect sizes for each intervention arm at 3 months and 12 months on point prevalence & incidence of PEs.
Univariate | Adjustment 1 Baseline PEs | Adjustment 2 Baseline PEs & other characteristics* | Incidence Removal of baseline PEs | |||||
|---|---|---|---|---|---|---|---|---|
OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | |||||
QPR | 3-month | 0.83 (0.19–3.65) | 0.79 (0.18–3.48) | 0.75 (0.16–3.45) | 1.06 (0.31–3.67) | |||
12-month | 0.30 (0.07–1.43) | 0.37 (0.08–1.65) | 0.39 (0.08–1.83) | 0.32 (0.10–1.07) | ||||
YAM | 3-month | 1.26 (0.35–4.47) | 1.25 (0.36–4.37) | 1.30 (0.37–4.56) | 1.06 (0.33–3.39) | |||
12-month | 0.53 (0.14-2.00) | 0.63 (0.17–2.30) | 0.75 (0.20–2.75) | 0.57 (0.18–1.79) | ||||
ProfScreen | 3-month | 0.71 (0.18–2.83) | 0.69 (0.18–2.76) | 0.67 (0.16–2.72) | 1.62 (0.49–5.35) | |||
12-month | 0.11 (0.02–0.58) | 0.14 (0.03–0.68) | 0.12 (0.02–0.62) | 0.30* (0.09–0.97) |